Christine E Farrar

Title: Christine E Farrar: Innovator in Protein Chemistry

Introduction

Christine E Farrar is a prominent inventor based in Newbury Park, CA (US). She has made significant contributions to the field of protein chemistry, holding a total of 5 patents. Her work focuses on the modification of proteins, which has important implications in various biotechnological applications.

Latest Patents

Among her latest patents, Christine has developed N-terminally chemically modified protein compositions and methods. These innovations include methods and compositions related to the attachment of water-soluble polymers to proteins. She has introduced novel methods for N-terminally modifying proteins or their analogs, resulting in compositions such as novel N-terminally chemically modified G-CSF compositions and related methods of preparation. Additionally, her work includes chemically modified consensus interferon, showcasing her expertise in this specialized area.

Career Highlights

Christine E Farrar is currently associated with Amgen Inc., a leading biotechnology company. Her role at Amgen has allowed her to further her research and development in protein chemistry, contributing to advancements in therapeutic solutions. Her innovative approaches have positioned her as a key figure in her field.

Collaborations

Christine has collaborated with notable colleagues, including Nancy E Gabriel and Olaf B Kinstler. These partnerships have fostered a collaborative environment that enhances the research and development of new protein-based therapies.

Conclusion

Christine E Farrar's contributions to protein chemistry through her patents and work at Amgen Inc. highlight her as a significant innovator in the field. Her research continues to pave the way for advancements in biotechnology and therapeutic applications.